Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06836141 · ClinicalTrials.gov registry record
Biomarkers for Cognitive Decline in Intracerebral Hemorrhage
A clinical trial of Primary Intracerebral Hemorrhage, sponsored by Rush University Medical Center.
- Recruiting
- Registry status
- 118
- Enrollment target
- 1
- Study location
NCT06836141: Recruiting study of Primary Intracerebral Hemorrhage, sponsored by Rush University Medical Center.
NCT06836141 is a study of Primary Intracerebral Hemorrhage that is actively recruiting participants, run by Rush University Medical Center. The registered enrollment target is 118 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06836141, a study of Primary Intracerebral Hemorrhage, is actively recruiting participants, sponsored by Rush University Medical Center.
- RECRUITING
- Registry status
- 118 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to see if silent brain infarcts (SBIs), or stroke-like symptoms detectable during brain imaging, are a possible contributor to cognitive decline for patients diagnosed with spontaneous intracerebral hemorrhage (sICH), or blood clot in the brain. The main questions it aims to answer are * if SBIs in sICH are associated with a lower cognitive level and more rapid cognitive decline * if SBIs in sICH are associated with certain findings on brain imaging * if SBIs in sICH are associated with higher inflammation measured by certain blood tests Participants will undergo * cognitive testing during hospitalization, and at 3, 6 and 12 months after the sICH * Magnetic Resonance Imaging (MRI) of the brain during hospitalization and 12 months after the sICH * blood draws during hospitalization and at 3, 6 and 12 months after the sICH
Primary Outcome
Assessed via the the Late Onset Alzheimer's Disease Family Study Cognitive Battery
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Blood Draw
- DIAGNOSTIC_TEST MRI
- DIAGNOSTIC_TEST Cognitive Test
Study Locations (1)
Illinois
- Rush University Medical Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 118 participants |
| Start Date | 2025-08-02 |
| Est. Completion | 2029-08-01 |
What NCT06836141 shows while recruiting
NCT06836141 is an observational study that tracks outcomes without assigning an intervention. The registered 118 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Primary Intracerebral Hemorrhage appearing as the primary indexed condition, and to 3 interventions - of which Blood Draw is the first listed.
NCT06836141 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06836141 about?
NCT06836141 is a clinical study titled "Biomarkers for Cognitive Decline in Intracerebral Hemorrhage". The goal of this clinical trial is to see if silent brain infarcts (SBIs), or stroke-like symptoms detectable during brain imaging, are a possible contributor to cognitive decline for patients diagnosed with spontaneous intracerebral hemorrhage (sICH), or blood clot in the brain. The main questions ...
What is the current status of trial NCT06836141?
This trial is currently recruiting. The enrollment target is 118 participants. The study started on 2025-08-02. Estimated completion is 2029-08-01.
What conditions does trial NCT06836141 study?
This clinical trial studies the following conditions: Primary Intracerebral Hemorrhage.
What interventions are being tested in trial NCT06836141?
The interventions under investigation include: Blood Draw (DIAGNOSTIC_TEST), MRI (DIAGNOSTIC_TEST), Cognitive Test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06836141?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06836141 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03821623 · 118 participants · Phase 2
Nicotinamide Riboside for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults
- NCT04040959 · 118 participants · Phase 2
Nicotinamide Riboside Supplementation for Treating Arterial Stiffness and Elevated Systolic Blood Pressure in Patients With Moderate to Severe CKD
- NCT04696029 · 118 participants · Phase 2
DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
- NCT05223192 · 118 participants · NA
The Effects of Entrainment on Respiratory Stability and Cerebral Oxygenation in Preterm Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI